Senior lecturer

Healthy Hearts Benefit from Daily Cranberry Consumption

Retrieved on: 
Tuesday, March 22, 2022
Risk, Blood, Farmer Research Committee, Heart, FMD, Clinical trial, Senior lecturer, Research, King's College London, Medical school, Incidence, Cardiovascular disease, Nutritional science, Health, Man, Cardiology, Committee, Industry, Proanthocyanidin, Fruit, Randomized controlled trial, Polyphenol, King, Vegetable, Department, University College London Hospitals NHS Foundation Trust, Cranberry, Education, University of Surrey, University, Dietary supplement, Nutrition

CARVER, Mass., March 22, 2022 /PRNewswire/ -- A new clinical trial in Food & Function found daily consumption of cranberries for one month improved cardiovascular function in healthy men. The new study, Daily consumption of cranberry improves endothelial function in healthy adults: a double blind randomized controlled trial, included 45 healthy men who consumed whole cranberry powder equivalent to 1 cup of cranberries per day (9 g powder) or a placebo for one month. Those consuming cranberry had a significant improvement in flow-mediated dilation (FMD), which signals improvement of heart and blood vessel function. FMD is considered a sensitive biomarker of cardiovascular disease risk and measures how blood vessels widen when blood flow increases.

Key Points: 
  • CARVER, Mass., March 22, 2022 /PRNewswire/ --A new clinical trial in Food & Function found daily consumption of cranberries for one month improved cardiovascular function in healthy men.
  • The new study, Daily consumption of cranberry improves endothelial function in healthy adults: a double blind randomized controlled trial , included 45 healthy men who consumed whole cranberry powder equivalent to 1 cup of cranberries per day (9 g powder) or a placebo for one month.
  • The study found significant improvements in FMD two hours after first consumption and after one month of daily consumption showing both immediate and chronic benefit.
  • To read the study in its entirety, theFood & Function article can be accessed here: Daily consumption of cranberry improves endothelial function in healthy adults: a double blind randomized controlled trial .

Frontiers in Immunology Paper Discloses Promising New Insights into CAR T Cell Efficacy for Cancer Therapies

Retrieved on: 
Thursday, March 17, 2022
Molecule, Senior lecturer, Solution, Technology, Health, King's College London, Pharmacy, School, King's College, Z movie, Cell, Research, Cancer, CAR, Drug development, Immune system, Acoustics, Biology, Frontiers, Vaccine, Immunology

The paper describes innovative research conducted at Kings College London under the auspices of Dr. John Maher, in collaboration with Leucid Bio, using LUMICKS' z-Movi Cell Avidity Analyzer.

Key Points: 
  • The paper describes innovative research conducted at Kings College London under the auspices of Dr. John Maher, in collaboration with Leucid Bio, using LUMICKS' z-Movi Cell Avidity Analyzer.
  • This new research suggests that adding a second targeting receptor to CAR T cells enhances their ability to target cancer cells and shows promise to improve immunotherapies for cancer in pre-clinical models.
  • New insights obtained using cell avidity measurements can really help improve the way we design cell therapies."
  • Similarly, the z-Movi Cell Avidity Analyzer enables the measurement and selection of immune cells based on their real-time interactions with target cells.

Frontiers in Immunology Paper Discloses Promising New Insights into CAR T Cell Efficacy for Cancer Therapies

Retrieved on: 
Thursday, March 17, 2022
Molecule, Senior lecturer, Solution, Technology, Health, King's College London, Pharmacy, School, King's College, Z movie, Cell, Research, Cancer, CAR, Drug development, Immune system, Acoustics, Biology, Frontiers, Vaccine, Immunology

The paper describes innovative research conducted at Kings College London under the auspices of Dr. John Maher, in collaboration with Leucid Bio, using LUMICKS' z-Movi Cell Avidity Analyzer.

Key Points: 
  • The paper describes innovative research conducted at Kings College London under the auspices of Dr. John Maher, in collaboration with Leucid Bio, using LUMICKS' z-Movi Cell Avidity Analyzer.
  • This new research suggests that adding a second targeting receptor to CAR T cells enhances their ability to target cancer cells and shows promise to improve immunotherapies for cancer in pre-clinical models.
  • New insights obtained using cell avidity measurements can really help improve the way we design cell therapies."
  • Similarly, the z-Movi Cell Avidity Analyzer enables the measurement and selection of immune cells based on their real-time interactions with target cells.

MedCann and Microdose Psychedelic Insights Announce Confirmed Speakers & Sponsors Plant Medicine Week

Retrieved on: 
Wednesday, March 9, 2022
Medical cannabis, Founder CEO, Senior, University, University of Malta, Department, Partner, Chair, Senior lecturer, Exhibition, Education, VICE, MD, Microdosing, Legislation, Doctor of Philosophy, Therapy, RSM, Malta Enterprise, Medicine, CEO, Management, Risk management, Research, Pharmacy, West Indies

Plant Medicine Week will take place April 5-8th 2022, at the Mediterranean Conference Centre, Triq l-Isptar, Il-Belt Valletta VLT 1645, Malta

Key Points: 
  • Valletta, Malta--(Newsfile Corp. - March 9, 2022) - Medical Cannabis World Forum and Microdose Psychedelics Insights , today announced the first line up of confirmed speakers and sponsors for the 1st annual conference, Plant Medicine Week .
  • Plant Medicine Week is a gathering of the latest perspectives and advances from the medical cannabis and psychedelic medicine industries.
  • A four-day conference bringing together an incredible community of experts for a deep dive into the world of plant medicine.
  • Vetted investors, top industry executives, service providers, clinicians will find tremendous value from participating in Plant Medicine Week.

MIT's Golub Center for Finance and Policy opens nomination period for the second biennial Miriam Pozen Prize, recognizing outstanding contributions to financial policy

Retrieved on: 
Tuesday, March 1, 2022
MIT Sloan School of Management, Retirement, MIT, Economy, Commission, Fidelity Investments, Senior lecturer, Organization, Center, Associate, Nature, Advisory Committee, Social Security, Multimedia, Institute, Management, MBA, Investment, MFS Investment Management, Research, Public sector, SEC, Pharmaceutical industry, Policy

As MIT's first-ever prize in financial policy , the Miriam Pozen Prize, currently an award of $200,000, is granted biennially for research or practice in financial policy by an academic or practitioner.

Key Points: 
  • As MIT's first-ever prize in financial policy , the Miriam Pozen Prize, currently an award of $200,000, is granted biennially for research or practice in financial policy by an academic or practitioner.
  • The Miriam Pozen Prize is awarded under the aegis of the MIT Golub Center for Finance and Policy (GCFP) at the MIT Sloan School of Management .
  • The prize supports improvements in financial policy by recognizing advancements in research and practice which is core to the mission of the MIT GCFP.
  • To nominate an individual for the Miriam Pozen Prize, please include:
    - a brief summary of the significant contributions the nominee has made in the field of financial policy.

Tidelift Achieves Key Milestones as Open Source Software Supply Chain Security Takes Center Stage

Retrieved on: 
Thursday, February 24, 2022
Health, Income, Innovation, Head, Government, Bloomberg, Adobe, Harvard Business School, Growth, White House, Software, CTO, Senior lecturer, HackNY, Industry, Organization, VP, AWS, SolarWinds, United, DigitalOcean, Woman, Jet Propulsion Laboratory, CVE, Akamai Technologies, Pressure, VMware, Amazon, Maintenance, Air force, IEEE, Technology, ISV, Solution, Log4j, NASA, Risk management, Netezza

Tidelift's accelerating momentum underscores the growing demand for new and innovative solutions that improve software supply chain health and security.

Key Points: 
  • Tidelift's accelerating momentum underscores the growing demand for new and innovative solutions that improve software supply chain health and security.
  • "If there is a silver lining, it is that because of Log4Shell, open source software supply chain security is finally getting the attention it deserves from government and industry leaders."
  • As a four-year Tidelift veteran, Lauren has been key to the design of the strategy and product vision that are improving open source software supply chain health for our customers and ensuring more open source maintainers get paid.
  • Through the Tidelift Subscription, the company delivers the tools, data, and strategies powering an inclusive and organization-wide approach to improving the health and security of the open source software supply chain.

Kimberly Parrish Joins Currance as Chief Operating Officer (COO)

Retrieved on: 
Tuesday, February 22, 2022
GLOBE, COO, Program, Growth, Stanford University Medical Center, University of Florida Health, Senior lecturer, University, MHA, NYU Langone Health, New York University, Atlantic Health System, Organization, University of Miami, Hennepin County Medical Center, Artificial intelligence, Technology, Solution, CEO, Hospital, Pharmaceutical industry

IRVINE, Calif., Feb. 22, 2022 (GLOBE NEWSWIRE) -- Currance, a leading healthcare revenue cycle industry innovator, announces the appointment of Kimberly Parrish to the position of Chief Operating Officer (COO).

Key Points: 
  • IRVINE, Calif., Feb. 22, 2022 (GLOBE NEWSWIRE) -- Currance, a leading healthcare revenue cycle industry innovator, announces the appointment of Kimberly Parrish to the position of Chief Operating Officer (COO).
  • Kimberly is a nationally recognized leader in revenue cycle consulting with over 30 years in healthcare management.
  • "In our continuing effort to exceed client expectations, we are excited to welcome Kimberly Parrish to Currance as our Chief Operating Officer.
  • Kim's revenue cycle insight will support our senior leadership's focus on solution innovation and exceptional customer support," said Michael Halberda, CEO of Currance.

Melissa Perri Joins Dragonboat's Board Of Advisors

Retrieved on: 
Monday, February 14, 2022
OKR, Harvard Business School, Insight Partners, Product management, Goal, Student, Melissa, Senior lecturer, View, PPM, Growth, Multimedia, MBA, Organization, Management, Dragon boat

SANTA CLARA, Calif., Feb. 14, 2022 /PRNewswire/ -- Dragonboat, the fastest growing product portfolio management platform, today announced the addition of Melissa Perri to its advisory board.

Key Points: 
  • SANTA CLARA, Calif., Feb. 14, 2022 /PRNewswire/ -- Dragonboat, the fastest growing product portfolio management platform, today announced the addition of Melissa Perri to its advisory board.
  • Melissa Perri is the world-renowned product leadership expert and author of "Escaping the Build Trap."
  • Melissa has extensive experience working with product leaders and their teams to develop best-in-class product processes and strategies.
  • Melissa Perri will join Becky Flint on stage at Product School's ProductCon event on February 17th to discuss driving an outcome-oriented strategy.

Jamf Empowers more than 36 Million Students Across the Globe with Apple

Retrieved on: 
Monday, January 31, 2022
Parent, Learning, Workflow, NASDAQ, University, Senior lecturer, Technology, JAMF, School, Student, GLOBE, Education, Weather, University of South Wales, Software, Mobile phone, Tutoring, Mac, Jamf, Apple

Considering the popularity of Apple and Jamf in education markets, and the percentage of devices that are shared amongst students, Jamf estimates that today it empowers more than 36 million students via one-to-one and shared Apple devices across more than 32,000 schools around the globe.

Key Points: 
  • Considering the popularity of Apple and Jamf in education markets, and the percentage of devices that are shared amongst students, Jamf estimates that today it empowers more than 36 million students via one-to-one and shared Apple devices across more than 32,000 schools around the globe.
  • Jamf powers the optimal digital experience using Apple devices to keep students focused and engaged no matter where they are learning.
  • Its flagship education product, Jamf School, recently surpassed five million devices, showcasing Jamf and Apple momentum in education.
  • Ability to focus students on every Apple device - Jamf extended key capabilities of Jamf Teacher to Mac classroom management workflows, allowing teachers to use the key features for students using any Apple device.

The PhD Project and Thought Leader James Rhee Explore Leading with Kindness

Retrieved on: 
Monday, January 24, 2022
Doctor of Philosophy, Global leadership, LinkedIn, JPMorgan Chase, The PhD Project, MIT Sloan School of Management, CEO, Learning, Student, Center, Q&A, Senior advisor, Native, Howard University, View, Facebook, Culture, Program, TED (conference), Capitalism, Mentorship, Work, Conscious business, PHD, Multimedia, Senior lecturer, Twitter, TED, Native Americans, Organization, Management, Woman, Entrepreneurship

The PhD Project hosted a watch party followed by a Live Q&A on Thursday, January 20, 2022.

Key Points: 
  • The PhD Project hosted a watch party followed by a Live Q&A on Thursday, January 20, 2022.
  • The PhD Project was thrilled to host this watch party and invite all who were interested in learning more about James Rhee's inspirational story," said Blane Ruschak, President of The PhD Project.
  • The PhD Project also includes close to 300 students currently enrolled in a business PhD program.
  • For more information on The PhD Project, webinars and sponsors visit www.phdproject.org and follow the program on Twitter , Facebook and LinkedIn .